PROX1 and neoplasm: When PROX1 expression levels (higher vs lower) were correlated with clinicopathological features and disease outcome (Table 1), there was no significant association with age group, tumor location, pTNM classification, pathological grade, lymphatic and/or PNI, and local recurrence.